A study to evaluate subcutaneous Daratumumab in combination with stafnard mutliple myeloma treatment regimens (54767414MMY2040)
A study to evaluate subcutaneous Daratumumab in combination with stafnard mutliple myeloma treatment regimens (54767414MMY2040)
Trial Category:
Hematologic
Phase
II
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
